SCHEMBL5846675

SCHEMBL5846675

CS(=O)(=O)OC(=O)C[C@@H](N)c1cccs1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.40
ALOX5 P09917 1/20 0.39
ALDH1A1 P00352 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
NPC1 O15118 1/20 0.36
HPGD P15428 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CES2 O00748 1/20 0.36
CES1 P23141 1/20 0.36
KEAP1 Q14145 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.35
SLC1A3 P43003 1/20 0.34
SLC1A2 P43004 1/20 0.34
SLC1A1 P43005 1/20 0.34
POLB P06746 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
CFD P00746 1/20 0.34
TP53 P04637 4/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1144378 0.86 RAB9A (0.40) RAB9AALOX5ALDH1A1MEN1KMT2A
SCHEMBL1143873 0.82 ALOX5 (0.43) RAB9AALOX5ALDH1A1MEN1KMT2A
SCHEMBL1520244 0.82 ALOX5 (0.43) RAB9AALOX5ALDH1A1MEN1KMT2A
SCHEMBL5846678 0.79 RAB9A (0.41) RAB9AALOX5ALDH1A1MEN1KMT2A
SCHEMBL14143065 0.79 ALDH1A1 (0.42) RAB9AALOX5ALDH1A1MEN1KMT2A
SCHEMBL6975656 0.79 ALDH1A1 (0.42) RAB9AALOX5ALDH1A1MEN1KMT2A
SCHEMBL5846668 0.79 RAB9A (0.41) RAB9AALOX5ALDH1A1MEN1KMT2A
SCHEMBL5720919 0.77 ALDH1A1 (0.41) RAB9AALOX5ALDH1A1MEN1KMT2A
SCHEMBL5846643 0.76 GBA1 (0.41) ALDH1A1KMT2ASMN1; SMN2
SCHEMBL5845490 0.76 GBA1 (0.41) ALDH1A1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1386901-B1 Method for producing an optically active beta-amino acid TAKASAGO PERFUMERY CO LTD (JP) 2015-07-01 EP disclosed
US-20060122418-A1 Method for producing an optically active beta-amino acid MATSUMURA KAZUHIKO 2006-06-08 US disclosed
US-7015348-B2 Method for producing an optically active β-amino acid TAKASAGO INTERNATIONAL CORPORATION (JP) 2006-03-21 US disclosed
US-20040023344-A1 Method for producing an optically activ beta-amino acid TAKASAGO INTERNATIONAL CORPORATION (JP) 2004-02-05 US disclosed
EP-1386901-A1 Method for producing an optically active beta-amino acid Takasago International Corporation (JP) 2004-02-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122418-A1 Method for producing an optically active beta-amino acid AADAT, DAO, BCAT2 RAB9A 1112/4885ALOX5 761/4885ALDH1A1 784/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.